Benzinga | Nov 22, 2021 10:57AM EST

Endo's Qwo Data Presented At American Society For Dermatologic Surgery's Annual Meeting

Endo International plc (NASDAQ:ENDP) announced today that data from clinical and non-clinical studies of Endo Aesthetics' Qwo(r) (collagenase clostridium histolyticum-aaes), which received FDA approval in July 2020 for the treatment of moderate to severe cellulite in the buttocks of adult women, were presented during the annual meeting of the American Society for Dermatologic Surgery (ASDS).

The data were highlighted in five oral presentations during the meeting, which took place virtually November 19-21, 2021.

* New data: Safety and Efficacy of Qwo(r) for Buttock Cellulite in Women With Skin of Color: a Pooled Analysis of Randomized, Placebo-Controlled Trials Authors: Valerie D. Callender, M.D.; Jeanine B. Downie, M.D., Jill Edgecombe, B.S.; Qinfang Xiang, Ph.D.; Kadriye Ciftci, M.D., Ph.D.; Sabrina Guillen Fabi, M.D.

* Reduction in Dimple Volume in Women With Buttock Cellulite Treated With Qwo(r) Authors: Lawrence S. Bass, M.D.; Michael P. McLane, Ph.D.; Elizabeth Rosenberg, FNP; Jill Edgecombe, B.S.; Saji Vijayan, M.B.B.S.; Qinfang Xiang, Ph.D.; Genzhou Liu, Ph.D.; Michael S. Kaminer, M.D.

* Enzymatic Subcision and Remodeling After Qwo(r) Subcutaneous Injection: A Porcine Tissue Histology Study Authors: Sachin M. Shridharani, M.D.; Shannon R. Dalton, Ph.D.; Saji Vijayan, M.B.B.S.; Ashish C. Bhatia, M.D.

* Real-World Effectiveness and Safety of Qwo(r): an Interim Analysis for the Treatment of Thigh Cellulite in Women Authors: Melanie Palm, M.D., M.B.A.; John H. Joseph, M.D.; Deanne Mraz Robinson, M.D.; Ashish C. Bhatia, M.D.; Sachin M. Shridharani, M.D.; Steven H. Dayan, M.D.; Lisa Donofrio, M.D.; Jose R. Montes, M.D.; Genzhou Liu, Ph.D.; David Hernandez, M.D.; Saji Vijayan, M.B.B.S.; Jill Edgecombe, B.S.; Sabrina Guillen Fabi, M.D.

* Assessment of Selected Mitigation Treatments on Injection-Site Bruising After Qwo(r) Injection For Buttock Cellulite in Women: An Interim Analysis of a Collaborative, Phase 4, Open-Label Trial Authors: Steven H. Dayan, M.D.; Brian S. Biesman, M.D.; Suzanne Kilmer, M.D.; Kadriye Ciftci, M.D., Ph.D.; Jill Edgecombe, B.S.; Genzhou Liu, Ph.D.; Michael P. McLane, Ph.D.; Brenda LaTowsky, M.D.